4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

(3-FLUORO-2-METHOXYPYRIDIN-4-YL)BORONIC ACID, 95.0%, 250mg

tert-butyl 4-(4-((8-ethyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)-2-fluorophenyl)piperazine-1-carboxylate, 98%, 500mg

Crisol de fusión 79 MF forma media alta, 60 ml, 5, 10 Pieza(s)

2-Amino-6-fluorobenzoic Acid>98.0%(HPLC)(T)1g

1-(2-Methyltetrahydrofuro[3,4-d][1,3]dioxol-2-yl)propan-2-one, 95%, 5g

5,6,7,8-Tetrahydroquinolin-6-amine hydrochloride, 1g

4-Chloro-6-(3-methoxyphenyl)-2-(methylthio)pyrimidine-5-carbonitrile, 98%, 1g

7-FLUORO-3-IODO-1H-INDAZOLE, 95%, 1g

2-{[(tert-butoxy)carbonyl](cyclopropylmethyl)amino}acetic acid, 95%, 1g

Hexacianoferrato(II) de potasio trihidrato, 1 kg

2-((Tert-butoxycarbonyl)amino)-3-(7-methyl-1H-indol-3-yl)propanoic acid, 98%, 250mg

2-(TOLUENE-4-SULFONYLAMINO)-BENZOIC ACID METHYL ESTER, 95.0%, 1g